Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma

Triple-negative breast carcinoma (TNBC) is an aggressive disease that has a poor prognosis since it lacks effective treatment methods. Neurotrophic tyrosine receptor kinase (NTRK) fusion genes are excellent candidates for targeted RTK inhibitor therapies and there are available targeted therapy drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shafei, Shi, Xiaohua, Ren, Xinyu, Li, Kaimi, Pang, Junyi, Liang, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418219/
https://www.ncbi.nlm.nih.gov/pubmed/34490345
http://dx.doi.org/10.3389/fmolb.2021.654387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418219/
https://www.ncbi.nlm.nih.gov/pubmed/34490345
http://dx.doi.org/10.3389/fmolb.2021.654387

Ejemplares similares